Literature DB >> 14748901

Hormonal changes with cholesterol reduction: a double-blind pilot study.

T Ormiston1, O M Wolkowitz, V I Reus, R Johnson, F Manfredi.   

Abstract

BACKGROUND: The lowering of high serum cholesterol levels may be associated with increased non-cardiac mortality due to behavioral changes, although such endpoints are likely rare.
OBJECTIVE: This current study sought to determine if hormonal changes accompany pharmacologically induced decreases in serum cholesterol levels.
METHOD: Cholesterol, dopamine, homovanillic acid (HVA), serotonin, 5-HIAA, testosterone, cortisol and pregnenolone were measured at baseline and after 4 weeks of treatment.
RESULTS: Subjects' cholesterol levels significantly declined within 4 weeks. Concomitant significant increase in dopamine and HVA were noted.
CONCLUSION: Although this study is limited in size, it raises the possibility that cholesterol-lowering drug treatment is associated with hormonal perturbations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14748901     DOI: 10.1111/j.1365-2710.2003.00540.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  3 in total

1.  Association of serum cholesterol and cholesterol-lowering drug use with serum sex steroid hormones in men in NHANES III.

Authors:  Alison M Mondul; Elizabeth Selvin; Sabine Rohrmann; Andy Menke; Manning Feinleib; Norma Kanarek; Nader Rifai; Adrian S Dobs; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2010-05-29       Impact factor: 2.506

2.  Acute Statin Administration Reduces Levels of Steroid Hormone Precursors.

Authors:  Edra London; Christina Tatsi; Steven J Soldin; Christopher A Wassif; Peter Backlund; David Ng; Leslie G Biesecker; Constantine A Stratakis
Journal:  Horm Metab Res       Date:  2020-02-10       Impact factor: 2.936

3.  Effect of atorvastatin on testosterone levels.

Authors:  Muhammad Ismail Shawish; Bahador Bagheri; Vijaya M Musini; Stephen P Adams; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2021-01-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.